oral glp 1 weight loss GLP-1 Pill Delivers Injection-Like Results in Clinical Trials A new oral GLP-1 medication

The primary outcome was a composite of a sustained decline in eGFR of at least 50%, ESKD, or death from renal or CV causes

restrictions common Cigna Generally requires PA and step therapy UnitedHealthcare Coverage varies by plan

Your decision should consider: Your starting A1c and weight Your heart, kidney, and liver health Other medications you take Potential side effects Insurance coverage and cost Whether you prefer a daily pill or a weekly injection How likely you are to take the medication consistently The best medication is not necessarily the one that produced the biggest results in a clinical trial

Its risks are systemic instead

& Dosiou, C